α2-antiplasmin and its deficiency: Fibrinolysis out of balance

Haemophilia

Volumn 14, Issue 6, 2008, Pages 1250-1254

  Carpenter, Shannon L ^a   Mathew, P ^b  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Antiplasmin; Bleeding; Deficiency; Fibrinolysis

Indexed keywords

ALPHA 2 ANTIPLASMIN; AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; DESMOPRESSIN ACETATE; FIBRIN GLUE; FRESH FROZEN PLASMA; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANEXAMIC ACID; ANTIPLASMIN; PLASMIN; PLASMINOGEN ACTIVATOR;

ALPHA 2 ANTIPLASMIN DEFICIENCY; ARTICLE; BLEEDING; CHROMOSOME MAP; CLINICAL FEATURE; CONGENITAL BLOOD CLOTTING DISORDER; DRUG MECHANISM; FIBRINOLYSIS; GENETIC ASSOCIATION; HEMATOMA; HUMAN; NONHUMAN; ONSET AGE; PATHOPHYSIOLOGY; PREOPERATIVE CARE; PRIORITY JOURNAL; PROTHROMBIN TIME; RECOMMENDED DRUG DOSE; THROMBOCYTE ACTIVATION; ADOLESCENT; AGE; AGED; ANIMAL; BLEEDING DISORDER; BLOOD; BLOOD CLOTTING TEST; CHILD; GENETICS; MALE; METABOLISM; MOUSE; PHYSIOLOGY; PLASMA; RARE DISEASE; REVIEW;

ADOLESCENT; AGE FACTORS; AGED; ANIMALS; ANTIFIBRINOLYTIC AGENTS; ANTIPLASMIN; BLOOD COAGULATION TESTS; CHILD; FIBRINOLYSIS; HEMORRHAGE; HEMORRHAGIC DISORDERS; HUMANS; MALE; MICE; PLASMA; PLASMIN; PLASMINOGEN ACTIVATORS; RARE DISEASES;

EID: 55949110318     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2008.01766.x     Document Type: Article

References (40)

1. 2-plasmin inhibitor and its congenital deficiency. J Thromb Haemost 2005; 3: 623-31.
2. 2-plasmin inhibitor and its congenital deficiency. J Thromb Haemost 2006; 4: 284-5.
3. Koie K, Kamiya T, Ogata K, Takamatsu J. Alpha2-plasmin-inhibitor deficiency (Miyasato disease). Lancet 1978; 2: 1334-6.
4. 2-antiplasmin: Complementary roles in regulating lysis of thrombi and plasma clots. J Thromb Haemost 2007; 5: 812-7.
5. Goodnight SH, Hathaway WE. Disorders of Hemostasis and Thrombosis: A Clinical Guide, 2nd edn. New York, NY: McGraw-Hill, 2001: 187-9.
6. 2-Antiplasmin: Potential therapeutic roles in fibrin survival and removal. Curr Med Chem 2004; 2: 303-10.
7. Sumi Y, Ichikawa Y, Nakamura Y, Miura O, Aoki N. Expression and characterization of pro alpha-2-antiplasmin inhibitor. J Biochem (Tokyo) 1989; 106: 703-7.
8. 2-antiplasmin interacts with endothelial cells. Br J Haematol 2006; 136: 472-9.
9. Favier R, Aoki N, de Moerloose P. Congenital alpha(2)-plasmin inhibitor deficiencies: A review. Br J Haematol 2001; 114: 4-10.
10. Juhan-Vague I, Alessi MC, Declerck PJ. Pathophysiology of fibrinolysis. Ballières Clin Haem 1995; 8: 329-43.
11. Cohn RD, Eklund E, Bergner AL et al. Intracranial hemorrhage as the initial manifestation of a congenital disorder of glycosylation. Pediatrics 2006; 118: E514-21.
12. Flanders MM, Phansalkar MS, Crist RA, Roberts WL, Rodgers GM. Pediatric reference intervals for uncommon bleeding and thrombotic disorders. J Pediatr 2006; 149: 275-7.
13. 2-plasmin inhibitor gene. Proc Natl Acad Sci USA 1988; 85: 6836-40.
14. Coughlin PB. Antiplasmin: The forgotten serpin? FEBS J 2005; 272: 4852-7.
15. 2-plasmin inhibitor in human plasma. Biochem J 1993; 291: 623-5.
16. 2-plasmin inhibitor: A report of three cases. J Bone Joint Surg Am 1996; 78: 1409-14.
17. 2-antiplasmin deficiency. Chest 1990; 97: 1488-90.
18. 2-Antiplasmin deficiency: An overlooked cause of hemorrhage. Am J Pediatr Hemotol Oncol 1993; 15: 328-30.
19. 2-antiplasmin deficiency. Thromb Res 1985; 40: 645-51.
20. 2 antiplasmin) gene with heterozygous deficiency and a bleeding tendency. Blood Coagul Fibrinolysis 2003; 14: 107-11.
21. Hayward CPM, Cina CS, Staunton M, Jurriaans E. Bleeding and thrombotic problems in a patients with alpha2 plasmin inhibitor deficiency. J Thromb Haemost 2005; 3: 399-401.
22. 2 antiplasmin deficiency in a child. Anesth Analg 1997; 84: 1147-9.
23. 2 2-plasmin inhibitor in three sisters. Haemostasis 1982; 11: 176-84.
24. 2-plasmin inhibitor or plasminogen activator inhibitor-1. Haemophilia 2004; 10: 669-74.
25. 2-antiplasmin. Blood 1982; 59: 1246-50.
26. 2-plasmin inhibitor deficiency. Pediatr Radiol 1998; 28: 978-80.
27. Yoshinaga H, Hirosawa S, Chung DH, Miyasaka N, Aoki N, Favier R. A novel point mutation of the splicing donor site in the intron 2 of the plasmin inhibitor gene. Thromb Haemost 2000; 84: 307-11.
28. 2-PI-Okinawa). J Biol Chem 1989; 264: 18213-9.
29. 2-antiplasmin. Blood 1982; 59: 1169-79.
30. Kettle P, Mayne EE. A bleeding disorder due to deficiency of alpha 2-antiplasmin. J Clin Pathol 1985; 38: 428-9.
31. 2-antiplasmin deficiency. Thromb Haemost 1988; 59: 96-100.
32. 2-plasmin inhibitor. Clin Nephrol 1998; 49: 335.
33. 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder. J Clin Invest 1987; 80: 1391-400.
34. Harish VC, Zhang L, Huff JD, Lawson H, Owen J. Isolated antiplasmin deficiency presenting as a spontaneous bleeding disorder in a 63-year-old man. Blood Coagul Fibrinolysis 2006; 17: 673-5.
35. 2- Antiplasmin gene deficiency in mice is associated with enhanced fibrinolytic potential without overt bleeding. Blood 1999; 93: 2274-81.
36. 2-antiplasmin does not affect murine adipose tissue development. J Thromb Haemost 2007; 5: 420-1.
37. 2- antiplasmin promotes heart failure via overrelease of VEGF after acute myocardial infarction. Blood 2002; 100: 2487-93.
38. 2-Antiplasmin on cardiovascular diseases. Curr Pharm Des 2006; 12: 841-7.
39. Kanno Y, Hirade K, Ishisaki A et al. Lack of alpha2-antiplasmin improves cutaneous wound healing via over-released vascular endothelial growth factor-induced angiogenesis in wound lesions. J Throm Haemost 2006; 4: 1602-10.
40. Lee KN, Jackson KW, Christiansen VJ, Chung KH, McKee PA. A novel plasma proteinase potentiates α2-antiplasmin inhibition of fibrin digestion. Blood 2004; 103: 3783-8.